Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
82,688,844
-
Shares change
-
+1,519,334
-
Total reported value, excl. options
-
$1,701,064,840
-
Value change
-
-$42,443,387
-
Put/Call ratio
-
156%
-
Number of buys
-
120
-
Number of sells
-
-127
-
Price
-
$20.58
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q3 2016
293 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q3 2016.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82,688,844 shares
of 93,104,451 outstanding shares and own 88.8% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (10,449,822 shares), VANGUARD GROUP INC (5,195,212 shares), Capital Research Global Investors (4,423,358 shares), SCOPIA CAPITAL MANAGEMENT LP (3,659,647 shares), STATE STREET CORP (3,100,595 shares), RENAISSANCE TECHNOLOGIES LLC (2,931,674 shares), BlackRock Fund Advisors (2,790,235 shares), ACADIAN ASSET MANAGEMENT LLC (2,777,044 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2,427,625 shares), and D. E. Shaw & Co., Inc. (2,223,285 shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.